dc.contributor.author |
Wangchuk P. |
|
dc.contributor.author |
Keller P.A. |
|
dc.contributor.author |
Pyne S.G. |
|
dc.contributor.author |
Sastraruji T. |
|
dc.contributor.author |
Taweechotipatr M. |
|
dc.contributor.author |
Rattanajak R. |
|
dc.contributor.author |
Tonsomboon A. |
|
dc.contributor.author |
Kamchonwongpaisan S. |
|
dc.date.accessioned |
2021-04-05T03:34:19Z |
|
dc.date.available |
2021-04-05T03:34:19Z |
|
dc.date.issued |
2012 |
|
dc.identifier.issn |
1934578X |
|
dc.identifier.other |
2-s2.0-84861505544 |
|
dc.identifier.uri |
https://ir.swu.ac.th/jspui/handle/123456789/14347 |
|
dc.identifier.uri |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84861505544&doi=10.1177%2f1934578x1200700507&partnerID=40&md5=32ca02c41f971064f9320f03e533e056 |
|
dc.description.abstract |
The chemical constituents and biological activities of Corydalis crispa (Fumariaceae) were investigated for the first time. The phytochemical study resulted in the isolation of nine known isoquinoline alkaloids: protopine (1), 13-oxoprotopine (2), 13-oxocryptopine (3), stylopine (4), coreximine (5), rheagenine (6), ochrobirine (7), sibiricine (8) and bicuculline (9), with complete NMR data for 2 and 3 provided here for the first time. Crude extracts exhibited significant anti-inflammatory (p<0.01) activity against TNF-α production in LPS activated THP-1 cells. The acetylcholinesterase inhibitory activity of compounds 2, 4 and 7 and the antiplasmodial activity of compound 5 against P. falciparum strains TM4/8.2 and K1CB1 (multidrug resistant strain) are reported here for the first time. Stylopine (4) did not show antimalarial activity against the K1CB1 strain in contrast to a previous report. This study generated a scientific basis for the use of this plant in Bhutanese traditional medicine, either individually or in combination with other medicinal ingredients to treat a broad range of disorders. This study also identified compound 5 as potential new antimalarial lead compound. |
|
dc.subject |
13 oxocryptopine |
|
dc.subject |
13 oxoprotopine |
|
dc.subject |
amoxicillin |
|
dc.subject |
amphotericin B |
|
dc.subject |
antibiotic agent |
|
dc.subject |
antiflagellate agent |
|
dc.subject |
antifungal agent |
|
dc.subject |
antiinflammatory agent |
|
dc.subject |
antimalarial agent |
|
dc.subject |
antitrypanosomal agent |
|
dc.subject |
bicuculline |
|
dc.subject |
chloroquine |
|
dc.subject |
coreximine |
|
dc.subject |
Corydalis crispa extract |
|
dc.subject |
cycloguanil |
|
dc.subject |
dexamethasone |
|
dc.subject |
galantamine |
|
dc.subject |
ochrobirine |
|
dc.subject |
pb 113 |
|
dc.subject |
plant extract |
|
dc.subject |
plant medicinal product |
|
dc.subject |
protopine |
|
dc.subject |
pyrimethamine |
|
dc.subject |
rheagenine |
|
dc.subject |
sibiricine |
|
dc.subject |
stylopine |
|
dc.subject |
unclassified drug |
|
dc.subject |
vancomycin |
|
dc.subject |
antibacterial activity |
|
dc.subject |
antifungal activity |
|
dc.subject |
antiinflammatory activity |
|
dc.subject |
antiprotozoal activity |
|
dc.subject |
article |
|
dc.subject |
Bhutan |
|
dc.subject |
biological activity |
|
dc.subject |
controlled study |
|
dc.subject |
Corydalis crispa |
|
dc.subject |
cytokine production |
|
dc.subject |
drug isolation |
|
dc.subject |
drug mechanism |
|
dc.subject |
drug screening |
|
dc.subject |
drug structure |
|
dc.subject |
enzyme inhibition |
|
dc.subject |
nonhuman |
|
dc.subject |
nuclear magnetic resonance |
|
dc.subject |
Papaveraceae |
|
dc.subject |
phytochemistry |
|
dc.subject |
Plasmodium falciparum |
|
dc.subject |
Corydalis |
|
dc.subject |
Fumariaceae |
|
dc.subject |
Plasmodium falciparum |
|
dc.title |
Phytochemical and biological activity studies of the Bhutanese medicinal plant corydalis crispa |
|
dc.type |
Article |
|
dc.rights.holder |
Scopus |
|
dc.identifier.bibliograpycitation |
Natural Product Communications. Vol 7, No.5 (2012), p.575-580 |
|
dc.identifier.doi |
10.1177/1934578x1200700507 |
|